INOVIO (NASDAQ: INO), a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that the company has dosed the first Phase 2 trial subject in its quest to develop the first vaccine against the Middle East Respiratory Syndrome (MERS). INOVIO’s Phase 2 trial is designed to evaluate INO-4700, its DNA vaccine candidate for the prevention of MERS, a disease in the coronavirus family for which there are no approved vaccines.
Gaithersburg’s Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses of NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The agreement covers the purchase of up to 100 million doses of the vaccine with the option for an additional 100 million doses through 2023.
UM School of Medicine and School of Pharmacy Researchers Identify Promising New Compounds to Potentially Treat Novel Coronaviruses | University of Maryland School of MedicinePublished on :
Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The [….]
Good News Stories of the Week – Featuring the Baltimore Spirits Company, Route One Apparel, and More.
Good News Stories of the Week – Featuring the Baltimore Spirits Company, Route One Apparel, and More. The coronavirus pandemic and its impacts are changing daily and are hard to [….]
“Claudia Towles owner of aMuse Toys said her company adjusted with the closure of non-essential businesses and shifted to retool the business for online orders, curbside pickup, and local deliveries.” [….]
Maryland’s Medicinal Cannabis Industry Responds to Ensure Safe Patient Access During COVID-19 Crisis
Maryland’s Medicinal Cannabis Industry Responds to Ensure Safe Patient Access During COVID-19 Crisis Amid unprecedented uncertainty, industry insiders encourage staff safety and stakeholder education for patient access Dispensaries, growers, processors [….]
Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages April 28, 2020 Longhorn Vaccines & Diagnostics, located in Bethesda, Maryland, is a privately-held, veteran-run company that develops [….]
Business Relief Wizard for COVID-19 Assistance Launches in Partnership with Maryland Tech Council Coalition
Business Relief Wizard for COVID-19 Assistance Launches in Partnership with Maryland Tech Council Coalition The Maryland Tech Council (MTC) has rapidly responded to the urgent needs of the region and [….]
Coronavirus Pandemic Good News Roundup from Around the BioHealth Capital Region While the number of cases and fatalities continue to devastate communities and families across the globe, recent COVID-19 news [….]
Coronavirus Pandemic Good News Roundup Sheds Light Amidst Trying COVID-19 Times Dr. Fauci, Dr. Birx and Surgeon General Dr. Adams of the Coronavirus Task Force have all been very honest [….]